[SYRE] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
29-Sep-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 81.52%
YoY- -119.96%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 1,042 0 688 198 168 -
PBT -38,837 -43,825 -63,180 -40,104 -217,074 -18,458 -18,784 62.36%
Tax 0 -32 -5,746 3 7 -36 38 -
NP -38,837 -43,857 -63,180 -40,107 -217,081 -18,422 -18,822 62.14%
Tax Rate - - - - - - - -
Total Cost 38,837 43,857 64,222 40,107 217,769 18,620 18,990 61.18%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 -6,063.34 0.00 -31,552.47 -9,304.04 -11,203.57 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.86 -1.20 -11.29 -9.34 -56.79 -4.89 -7.20 -75.77%
EPS Diluted -0.86 -1.20 -11.29 -9.34 -56.79 -4.89 -7.20 -75.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.